MDR-1339
目录号: A21138
Aβ-aggregation inhibitor
MDR-1339(DWK-1339)是一种口服活性且能穿透血脑屏障的Aβ聚集抑制剂,用于阿尔茨海默病的研究。
Discription | MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease. |
---|
目录号 | A21138 |
---|---|
分子式 | C20H22O4 |
分子量 | 326.39 |
CAS号 | 1018946-38-7 |
SMILES | COCCCC1=CC=C(OC(C2=CC=C(OC)C(OC)=C2)=C3)C3=C1 |
其他名称 | MDR 1339, MDR1339, DWK-1339, DWK1339, DWK 1339 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2